Long-chain PFAS, including PFOS and PFOA, have bioaccumulative and toxic characteristics, unlike the short-chain PFAS present in current foams (AFFF). Despite this, in recent years, legislators and regulators have advocated for a group-wide regulation of all PFAS substances. Consequently, various states across the United States have enacted legislation that limits the sale and application of aqueous film-forming foam (AFFF).
You can also read: Anticipating Change: The Move to Siloxane-Free PPAs
The Fire Fighting Foam Coalition (FFFC) provides a concise overview of the legislative measures enacted or proposed in various states. Click here for the complete document.
Implemented restrictions starting January 1, 2022, for PFAS-containing AFFF.
Allowed uses include federal law requirements or systems with 110% containment until specified dates.
Since August 2, 2019, restrictions on AFFF discharge for training/testing unless containment measures are in place.
Detailed usage guidelines set forth post-August 2, 2021, with particular exemptions for specific facilities.
From October 1, 2021, bans on PFAS foams for training/testing and limits on vapor suppression or firefighting applications unless no alternatives exist.
Beginning January 1, 2022, prohibitions on training/testing uses of PFAS foams with mandates for alternative containment and disposal solutions by 2025.
Effective January 1, 2022, stringent controls on PFAS foam discharge with phased usage restrictions and recall requirements.
Legislation from October 1, 2021, focusing on training and testing prohibitions with mandated containment and treatment measures.
A phased approach from 2024, detailing exemptions based on federal requirements and specific industrial applications.
Early adopter with restrictions from January 1, 2020, including sales limitations and requirements for containment and recall protocols.
Established a timeline from May 18, 2022, for restricted sales/distribution and detailed compliance measures for manufacturers.
From July 1, 2022, prohibitions on AFFF for non-essential uses with a future ban on manufacturing and sales set for October 1, 2023.
Early legislation starting July 1, 2018, for training uses, expanding to sales/distribution controls by 2020 with phased restrictions.
States like Arizona, Georgia, Indiana, Kentucky, Michigan, Nevada, Virginia, and Wisconsin have enacted legislation focusing primarily on using PFAS foams for training and testing, though specifics and enforcement details vary.
In oncology, polymers have become powerful tools for boosting cancer treatment efficacy and patient compliance.
AQUACHILL™ Dispersion coating emerges as an innovative solution to address cool-touch performance in bedding clothes.
Recent research has unveiled the potential of polymer materials as effective catalysts in environmental remediation,…
Did you know that during a hailstorm, your home's roof is at risk of damage?…
Researchers at Washington State University have developed an exciting new conductive, cotton-based fiber that melds…
A recent study introduces hydrogel coatings for medical catheters to significantly reduce friction and prevent…